STATISTICAL METHODS FOR CASE CONTROL SURVIVAL DATA
病例对照生存数据的统计方法
基本信息
- 批准号:6497997
- 负责人:
- 金额:$ 8.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-02-15 至 2004-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
APPLICANT'S DESCRIPTION The aim of this two year project is to develop and test new statistical methods for the analysis of prevalence case-control survival data. Prevalence case-control survival studies may be a powerful approach to study time to onset of disease, and to evaluate the association between risk factors and probability of developing the disease. In many cases, prevalence case-control survival studies are more efficient than incidence case-control or prospective cohort studies. Unfortunately, no statistical methods are currently available for an efficient analysis of data from prevalence case-control survival studies. The specific aims of this project are: 1) To extend methods for the analysis of data from prevalence case-control studies developed in the setting of the one-sample problem (no covariates included in the analysis) to the setting of the two-sample problem, i.e., to develop methods for estimating and comparing survival distributions for two different risk groups; 2) To use the methods developed in Aim (1) to analyze survival data from a prevalence case-control sample of patients with adenomatous polyps (adenomas); 3) To develop regression methods for the analysis of prevalence case-control survival data; 4) To develop user-friendly software for the analysis of survival data from prevalence case-control studies. Development of the new methods is based on an extension of the usual approach to the analysis of case-control data of embedding the case-control likelihood into a prospective likelihood, and on methods of analysis of right truncated survival data. The methodological as well as epidemiological relevance of this proposal is that it provides appropriate and efficient methods of analysis of data from prevalence case-control survival data.
这个为期两年的项目的目的是开发和测试新的统计方法,用于分析流行病例-对照生存数据。流行病例对照生存研究可能是研究发病时间和评估危险因素与发病概率之间关系的有力方法。在许多情况下,流行病例对照生存研究比发病率病例对照或前瞻性队列研究更有效。不幸的是,目前没有统计方法可用于有效分析流行病例-对照生存研究的数据。该项目的具体目标是:1)将在单样本问题(分析中不包括协变量)的情况下开发的患病率病例对照研究数据的分析方法扩展到双样本问题的设置,即开发估算和比较两个不同风险群体的生存分布的方法;2)使用Aim(1)中开发的方法分析腺瘤性息肉(adenomatous polyps,腺瘤)患者患病率病例对照样本的生存数据;3)发展流行病例-对照生存数据的回归分析方法;4)开发用户友好的软件,用于分析流行病例对照研究的生存数据。新方法的发展是基于对病例-对照数据分析的通常方法的扩展,即将病例-对照似然嵌入到预期似然中,以及对右截断生存数据的分析方法。该建议的方法学和流行病学相关性在于,它提供了适当和有效的方法来分析来自流行病例-对照生存数据的数据。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Estimating and comparing the distribution of onset of disease from prevalence case-control data.
根据患病率病例对照数据估计和比较疾病发作的分布。
- DOI:10.1111/j.1541-0420.2005.00407.x
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Bagiella,Emilia
- 通讯作者:Bagiella,Emilia
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Emilia Bagiella其他文献
Emilia Bagiella的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Emilia Bagiella', 18)}}的其他基金
Hybrid Coronary Revascularization Trial- DCC
混合冠状动脉血运重建试验 - DCC
- 批准号:
9534725 - 财政年份:2016
- 资助金额:
$ 8.53万 - 项目类别:
The Applied Statistics in Biological Systems (ASIBS) Short Course
生物系统应用统计学(ASIBS)短期课程
- 批准号:
8853106 - 财政年份:2015
- 资助金额:
$ 8.53万 - 项目类别:
The Applied Statistics in Biological Systems (ASIBS) Short Course
生物系统应用统计学(ASIBS)短期课程
- 批准号:
9059139 - 财政年份:2015
- 资助金额:
$ 8.53万 - 项目类别:
The Applied Statistics in Biological Systems (ASIBS) Short Course
生物系统应用统计学(ASIBS)短期课程
- 批准号:
9241407 - 财政年份:2015
- 资助金额:
$ 8.53万 - 项目类别:
Factors determining placebo response in drug-resistant focal epilepsy
决定耐药局灶性癫痫安慰剂反应的因素
- 批准号:
8670039 - 财政年份:2013
- 资助金额:
$ 8.53万 - 项目类别:
Factors determining placebo response in drug-resistant focal epilepsy
决定耐药局灶性癫痫安慰剂反应的因素
- 批准号:
8583010 - 财政年份:2013
- 资助金额:
$ 8.53万 - 项目类别:
From Cell to Society: A New Method to Characterize Cardiac Autonomic Control
从细胞到社会:表征心脏自主控制的新方法
- 批准号:
7503516 - 财政年份:2007
- 资助金额:
$ 8.53万 - 项目类别:
From Cell to Society: A New Method to Characterize Cardiac Autonomic Control
从细胞到社会:表征心脏自主控制的新方法
- 批准号:
7846879 - 财政年份:2007
- 资助金额:
$ 8.53万 - 项目类别:
From Cell to Society: A New Method to Characterize Cardiac Autonomic Control
从细胞到社会:表征心脏自主控制的新方法
- 批准号:
7364111 - 财政年份:2007
- 资助金额:
$ 8.53万 - 项目类别:
From Cell to Society: A New Method to Characterize Cardiac Autonomic Control
从细胞到社会:表征心脏自主控制的新方法
- 批准号:
7625207 - 财政年份:2007
- 资助金额:
$ 8.53万 - 项目类别:
相似海外基金
Urinary Phthalate Biomarker Concentrations and Breast and Prostate Cancer Risk in a National Cohort of Adults in Canada
加拿大全国成人队列中尿液邻苯二甲酸盐生物标志物浓度与乳腺癌和前列腺癌风险
- 批准号:
494953 - 财政年份:2023
- 资助金额:
$ 8.53万 - 项目类别:
Operating Grants
Prospective metabolomics investigation of gastric cancer risk in African Americans and European Whites with a low socioeconomic status
社会经济地位较低的非裔美国人和欧洲白人胃癌风险的前瞻性代谢组学调查
- 批准号:
10912190 - 财政年份:2023
- 资助金额:
$ 8.53万 - 项目类别:
Deep Learning Image Analysis Algorithms to Improve Oral Cancer Risk Assessment for Oral Potentially Malignant Disorders
深度学习图像分析算法可改善口腔潜在恶性疾病的口腔癌风险评估
- 批准号:
10805177 - 财政年份:2023
- 资助金额:
$ 8.53万 - 项目类别:
Clinical breast cancer risk prediction models for women with a high-risk benign breast diagnosis
高风险良性乳腺诊断女性的临床乳腺癌风险预测模型
- 批准号:
10719777 - 财政年份:2023
- 资助金额:
$ 8.53万 - 项目类别:
Developing diagnostics of patient-specific cancer risk and early-stage tumorigenesis
开发患者特异性癌症风险和早期肿瘤发生的诊断方法
- 批准号:
478999 - 财政年份:2023
- 资助金额:
$ 8.53万 - 项目类别:
Operating Grants
Environmental Metal Exposures and Breast Cancer Risk: A Prospective Study of Nationally Representative Canadian Data
环境金属暴露与乳腺癌风险:加拿大全国代表性数据的前瞻性研究
- 批准号:
495159 - 财政年份:2023
- 资助金额:
$ 8.53万 - 项目类别:
Mechanisms of tamoxifen-associated endometrial cancer risk
他莫昔芬相关子宫内膜癌风险的机制
- 批准号:
10650054 - 财政年份:2023
- 资助金额:
$ 8.53万 - 项目类别:
Gut microbiota-related mechanisms that impact colorectal cancer risk after bariatric surgery
影响减肥手术后结直肠癌风险的肠道微生物相关机制
- 批准号:
10733566 - 财政年份:2023
- 资助金额:
$ 8.53万 - 项目类别:
Obesity, body fat distribution, and breast cancer risk: is visceral fat the culprit after menopause?
肥胖、身体脂肪分布和乳腺癌风险:内脏脂肪是绝经后的罪魁祸首吗?
- 批准号:
10586626 - 财政年份:2023
- 资助金额:
$ 8.53万 - 项目类别:
Optimization of a personalized skin cancer risk intervention for at-risk young adults
针对高危年轻人的个性化皮肤癌风险干预措施的优化
- 批准号:
10582944 - 财政年份:2023
- 资助金额:
$ 8.53万 - 项目类别:














{{item.name}}会员




